Back to Search
Start Over
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines:A Systematic Review
- Source :
- Bruckert, E, Parhofer, K G, Gonzalez-Juanatey, J R, Nordestgaard, B, Arca, M, Giovas, P & Ray, K 2020, ' Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines : A Systematic Review ', Advances in Therapy, vol. 37, no. 5, pp. 1724-1736 . https://doi.org/10.1007/s12325-020-01285-2, Advances in Therapy, Advances in Therapy, Springer Verlag (Germany), 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩, Advances in Therapy, 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩
- Publication Year :
- 2020
-
Abstract
- Objective Assess achievement of low-density lipoprotein cholesterol (LDL-C) targets in European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines. Design Systematic literature review. Data Sources Medline, EMBASE, Cumulated Index to Nursing and Allied Health Literature. Eligibility Criteria Observational studies reporting LDL-C levels/target attainment, measured between 1 August 2006 to 31 August 2017, in European adults with established cardiovascular disease (CVD), diabetes with target organ damage, familial hypercholesterolaemia (FH) or 10-year risk of fatal CVD ≥ 5% (assessed by Systematic Coronary Risk Evaluation [SCORE]). Data Extraction and Synthesis Two reviewers independently extracted relevant studies and assessed study quality using the Risk of Bias for Non-Randomised Studies–Interventions (ROBINS-I) tool. Primary outcome was the proportion of patients achieving LDL-C targets in the 2011/2016 ESC/EAS guidelines. Where available, patient characteristics were presented as means weighted by sample size. The proportions of patients achieving LDL-C targets in the 5 years before and after publication of the 2011 guidelines were compared using a chi-square test. Results Across 81 eligible studies (303,534 patients), achievement of LDL-C
- Subjects :
- Adult
Male
030213 general clinical medicine
medicine.medical_specialty
LDL-C targets
Medication Therapy Management
[SDV]Life Sciences [q-bio]
High-risk
MEDLINE
Review
Disease
Guidelines
Hyperlipoproteinemia Type II
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Diabetes mellitus
medicine
Humans
Pharmacology (medical)
Low-density lipoprotein cholesterol
General Clinical Medicine
Cardiovascular disease
Systematic review
Aged
Aged, 80 and over
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
business.industry
Cholesterol, LDL
General Medicine
Middle Aged
medicine.disease
Rheumatology
3. Good health
Europe
[SDV] Life Sciences [q-bio]
Cardiovascular Diseases
Sample size determination
030220 oncology & carcinogenesis
Practice Guidelines as Topic
Female
Observational study
1115 Pharmacology and Pharmaceutical Sciences
business
Very high risk
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- Language :
- English
- ISSN :
- 0741238X
- Database :
- OpenAIRE
- Journal :
- Bruckert, E, Parhofer, K G, Gonzalez-Juanatey, J R, Nordestgaard, B, Arca, M, Giovas, P & Ray, K 2020, ' Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines : A Systematic Review ', Advances in Therapy, vol. 37, no. 5, pp. 1724-1736 . https://doi.org/10.1007/s12325-020-01285-2, Advances in Therapy, Advances in Therapy, Springer Verlag (Germany), 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩, Advances in Therapy, 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩
- Accession number :
- edsair.doi.dedup.....6fb35706845713d08a1f802628a57d3f